University Of Pittsburgh - Of The Commonwealth System Of Higher Education
Federal contracts 3
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $24.3M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Health and Human Services
Office of Assistant Secretary for Preparedness and Response |
$18.2M | FY 2026 | 5 | $22.7M → $3.0M → $1.3M → $18.2M | 75A50123C00047 |
PROVIDE DEFINITIVE EVIDENCE ON THE EFFECTIVENESS, SAFETY, AND MECHANISMS OF LOW TITER GROUP O WHOLE BLOOD (LTOWB) AND TRANEXAMIC ACID (TXA) AS RESUSCITATION STRATEGIES FOR THE TREATMENT OF LIFE-THREATENING BLEEDING SECONDARY TO TRAUMATIC INJURY IN CH | |||||
| Department of Defense
Defense Health Agency |
$4.2M | FY 2025 | 21 | $10.4M → $7.9M → $4.2M | HT942524C0121 |
SEMI CLOSED LOOP CONTROL CARDIOVASCULAR RESUSCITATION FOR PROLONGED FIELD CARE RESEARCH PROJECT/AWARD | |||||
| Department of Veterans Affairs
Department of Veterans Affairs |
$1.9M | FY 2026 | 72 | $2.5M → $1.7M → $1.9M | 36C24E26N0193 |
EO 14398 HERL/WARE TECH TRANSFER ASSISTED PROGRAM | |||||
Federal subcontractors 12
Companies this contractor subcontracted work to on federal prime contracts. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.
| Company | Subawards | Fiscal year | Count | Trend | Largest subaward |
|---|---|---|---|---|---|
| Med-ally, LLC | $4.1M | FY 2025 | 1 | N6600120C4050 | |
RESEARCH IAW SOW (BASE)AWARD TO UPITT (BG PLUS) | |||||
| Thermaquil, INC. | $3.3M | FY 2025 | 1 | N6600120C4050 | |
RESEARCH IAW SOW (BASE)AWARD TO UPITT (BG PLUS) | |||||
| Metrohealth System, The | $1.6M | FY 2025 | 1 | W81XWH20F0383 | |
PHYSIOLOGIC AGE OF WHOLE BLOOD | |||||
| The Administrators Of Tulane Educational Fund | $874.6K | FY 2025 | 2 | W81XWH18F0426 | |
PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD | |||||
| Oregon Health & Science University | $694.8K | FY 2025 | 1 | W81XWH18F0426 | |
PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD | |||||
| Regents Of The University Of California, SAN Francisco, The | $672.0K | FY 2025 | 1 | W81XWH19F0539 | |
THE PAIN TRIAL IS A 4 YEAR (3-YEAR ENROLLMENT) MULTICENTER, PREHOSPITAL, RANDOMIZED, DOUBLE-BLIND, CLINICAL TRIAL COMPARING FENTANYL VERSUS SUB-DISSOCIATIVE KETAMINE FOR MORTALITY OUTCOME DIFFERENCES, SAFETY, AND ANALGESIA IN TRAUMA PATIENTS WITH COMPENSATED SHOCK. | |||||
| Hennepin Healthcare Research Institute | $620.2K | FY 2025 | 1 | W81XWH22F0118 | |
NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL | |||||
| University Of Missouri System | $567.0K | FY 2025 | 1 | W81XWH22F0118 | |
NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL | |||||
| East Carolina University | $558.5K | FY 2025 | 1 | W81XWH18F0426 | |
PREHOSPITAL AIRWAY CONTROL TRIAL BASE AWARD | |||||
| University Of Vermont & State Agricultural College | $552.0K | FY 2025 | 1 | W81XWH19F0539 | |
UNIVERSITY OF VERMONT WILL PARTICIPATE IN THE PERFORMANCE OF A PROSPECTIVE, INTERVENTIONAL, RANDOMIZED TRIAL AMONG PREHOSPITAL TRAUMA PATIENTS WITH COMPENSATED SHOCK (SI>0.9) AND AN INDICATION FOR PAIN MANAGEMENT COMPARING KETAMINE HYDROCHLORIDE VERSUS FENTANYL CITRATE PER ATTACHMENT 3 OF THIS AGREEMENT. | |||||
| Cincinnati Univ Of | $528.8K | FY 2025 | 1 | W81XWH19F0539 | |
SERVE AS A CLINICAL SITE FOR TASK ORDER 006: PREHOSPITAL ANALGESIA INTERVENTION (PAIN) TRIAL, A 4 YEAR (3-YEAR ENROLLMENT) MULTICENTER, PREHOSPITAL, RANDOMIZED, DOUBLE-BLIND, CLINICAL TRIAL COMPARING FENTANYL VERSUS SUB-DISSOCIATIVE KETAMINE FOR MORTALITY OUTCOME DIFFERENCES, SAFETY AND ANALGESIA IN TRAUMA PATIENTS WITH COMPENSATED SHOCK. | |||||
| University Of Maryland, Baltimore | $500.0K | FY 2025 | 1 | W81XWH22F0118 | |
NEW LITES ORDER TASK ORDER 0010 CAVALIER TRIAL | |||||
Federal subcontracts received 2
Prime contractors that subcontracted federal work to this company. From USAspending.gov subaward reports; amounts are as reported by the prime contractor, latest report per subaward, $500K+ a year.
| Company | Subawards | Fiscal year | Count | Trend | Largest subaward |
|---|---|---|---|---|---|
| LDOS Leidos Holdings, Inc. |
$1.7M | FY 2025 | 3 | 75N91024F00021 | |
PCL-02 M3 SUBCONTRACTS | |||||
| Trustees Of The University Of Pennsylvania, The | $590.1K | FY 2025 | 2 | 75N93021C00015 | |
LE SAGE SCOPE OF WORK FOR PENN-CEIRR OPTION 18.L THIS CEIRR CONCEPT PROPOSAL HAS TWO DISTINCT AIMS THAT WILL ENABLE CHARACTERIZATION OF H5N1 HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI) VIRUS IN TERMS OF HOST AND ENVIRONMENTAL FACTORS THAT AFFECT TRANSMISSIBILITY. H5N1 HPAI STRAINS THAT ARE IMPORTANT TO THE DAIRY CATTLE OUTBREAK WILL BE ASSESS IN THE FOLLOWING AIMS. THERE ARE MANY IN VITRO CHARACTERISTICS THAT HAVE AN IMPACT ON EFFICIENT TRANSMISSION OF INFLUENZA VIRUS. IN AIM 1, I WILL CHARACTERIZE H5N1 HPAI STRAINS TO BETTER UNDERSTAND HOST TROPISM AND ENVIRONMENTAL STABILITY. THE FOLLOWING TASKS WILL BE ACCOMPLISHED: 1. EXAMINE REPLICATION KINETICS OF H5N1 HPAI IN PRIMARY HUMAN AIRWAY EPITHELIAL CELLS AND COMPARE IT TO A SEASONAL INFLUENZA VIRUS. 2. PERFORM SINGLE CELL RNA SEQUENCING ON THE INFECTED PRIMARY HUMAN AIRWAY EPITHELIAL CELLS TO COMPARE HOST TROPISM BETWEEN H5N1 HPAI AND SEASONAL INFLUENZA VIRUS. 3. COMPARE THE SECRETED CYTOKINES AND CHEMOKINES FROM H5N1 HPAI OR SEASONAL INFLUENZA VIRUS INFECTED PRIMARY HUMAN AIRWAY EPITHELIAL CELLS USING LUMINEX ASSAY. 4. DETERMINE THE ENVIRONMENTAL STABILITY UNDER A RANGE OF RELATIVE HUMIDITIES IN STATIONARY DROPLETS THAT CONTAIN MUCUS, COLLECTED FROM PRIMARY HUMAN AIRWAY EPITHELIAL CELLS. PRE-EXISTING IMMUNITY IS AN IMPORTANT BARRIER TO INFLUENZA VIRUS TRANSMISSION. IN AIM 2, I WILL ASSESS THE IMPACT OF SEASONAL VACCINATION IN FERRETS PRIOR TO CHALLENGE WITH H5N1 HPAI. THE FOLLOWING TASKS WILL BE ACCOMPLISHED: 1. PERFORM FERRET PATHOGENESIS AND SURVIVAL STUDIES IN FERRETS THAT HAVE BEEN VACCINATED WITH A SEASONAL INFLUENZA VIRUS THREE MONTHS PRIOR TO INTRANASAL CHALLENGE. 2. AS AIRBORNE TRANSMISSION IS NOT EFFICIENT FOR HPAI STRAINS, I WILL LEVERAGE THE AEROBIOLOGY CORE AT THE UNIVERSITY OF PITTSBURGH TO COMPARE THE SUSCEPTIBILITY OF VACCINATED FERRETS TO AEROSOL CHALLENGE OF H5N1 HPAI CHALLENGE. 3. PERFORM SEROLOGICAL ASSAYS TO DETERMINE THE LEVELS OF CROSS-REACTIVE HA AND NA ANTIBODIES GENERATED BY THESE VACCINATED FERRETS BEFORE AND AFTER CHALLENGE. | |||||
Alerts are coming
Get an email when University Of Pittsburgh - Of The Commonwealth System Of Higher Education's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.